Ticker
SGMOCompany Name
SANGAMO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Gross Profit | Gross Profits to Assets |
---|---|---|---|
6/30/2025 | $ 97.56M | $ 81.71M | 83.75% |
3/31/2025 | $ 86.17M | $ 63.76M | 73.99% |
12/31/2024 | $ 101.64M | $ 57.8M | 56.87% |
9/30/2024 | $ 111.26M | $ 52.29M | 47% |
6/30/2024 | $ 93.01M | $ 12.28M | 13.2% |
3/31/2024 | $ 128.96M | $ 18.76M | 14.54% |
12/31/2023 | $ 165.32M | $ 176.23M | 106.6% |
9/30/2023 | $ 219.7M | $ 201.42M | 91.68% |
6/30/2023 | $ 325.07M | $ 218.48M | 67.21% |
3/31/2023 | $ 440.57M | $ 241.03M | 54.71% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Assets
(=) GPA
GPA for SANGAMO THERAPEUTICS INC is calculated as follows: GP [ $ 147.24M ] / Assets [ $ 963.71M ]
(=) GPA [ 15.28% ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 4.13K |
---|---|
min | -50.32% |
max | 83.98% |
average | 20.16% |
median | 15.35% |
std | 19.95% |